← Back to Search

Anti-infective Irrigation Therapy

vancomycin-tobramycin-itraconazole for Foot Ulcer

Phase < 1
Waitlist Available
Led By Laura R Vick, MD
Research Sponsored by University of Mississippi Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will evaluate the effectiveness of a compounded, anti-infective irrigation therapy to increase the healing rates of diabetic foot ulcers.

Eligible Conditions
  • Foot Ulcer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Healing Rate
Secondary outcome measures
Wound Closure

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment of Diabetic Foot UlcerExperimental Treatment1 Intervention
Participants with diabetic foot ulcers will be treated with a compounded, anti-infective irrigation therapy daily until closure of the ulcer or up to a maximum of 3 months. This is an irrigating foot bath with a compounded medication of vancomycin-tobramycin-itraconazole. This medication with combined 3/4 gallon of water. Participant will soak foot in solution for 10 minutes per day. Daily until wound is healed for a minimum of 4 weeks and a maximum of 3 months.

Find a Location

Who is running the clinical trial?

University of Mississippi Medical CenterLead Sponsor
173 Previous Clinical Trials
194,987 Total Patients Enrolled
Keystone PharmacyUNKNOWN
Laura R Vick, MDPrincipal InvestigatorUniversity of Mississippi Medical Center

Frequently Asked Questions

~25 spots leftby Apr 2025